Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Capricor Therapeutics
(4LN2.F) Q2 2026
Earnings
4LN2.F
May 12
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.5
-0.43
-0.36
-0.28
Details
Expected EPS
-0.44546893543000005
Actual EPS
-0.5026741
Surprise EPS
-0.06
Surprise Percent
-12.84%
Description
Capricor Therapeutics (4LN2.F) has reported earnings of -0.5026741 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login